Stempeutics’ allogeneic cell therapy gets DCGI approval, Cipla to market and distribute…
Indicated for the treatment of CLI due to Buerger’s Disease and Atherosclerotic Peripheral Arterial Disease, it is the first…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
allogeneic cell therapy
DCGI gives limited approval to market Stempeutics’ allogeneic cell therapy
Stempeucel is used in the treatment of Buerger’s disease